Genomically-Guided Treatment Trial in Brain Metastases
More Information
- Trial Status
- Accepting patients
- Trial Phase
- Phase 2
- Enrollment
- 150 patients (estimated)
- Sponsors
- Alliance for Clinical Trials in Oncology
- Collaborators
- National Cancer Institute (NCI), Genentech
- Tags
- PI3K Inhibitor, Tyrosine Kinase (TK) Inhibitor, CDK6
- Trial Type
- Treatment
- Last Update
- 3 months ago
- SparkCures ID
- 1400
- NCT Identifier
- NCT03994796
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.